NCT06974799View on ClinicalTrials.gov

Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

July 15, 2024

Study Completion Date

January 18, 2025

Conditions
Pulmonary Fibrosis
Interventions
DIAGNOSTIC_TEST

Fatty acids measurement

Serum analysis for metabolomic biomarker identification

Trial Locations (1)

80131

UOC Clinica Pneumologica L Vanvitelli, Naples

All Listed Sponsors
collaborator

Ceinge - Biotecnologie Avanzate s.c. a r.l.

UNKNOWN

lead

University of Campania Luigi Vanvitelli

OTHER

NCT06974799 - Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter